Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia”

Lignende værker

• Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia
  af: Perrotti, Danilo, et al.
  Udgivet: (2012)
• Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells
  af: Guerzoni, Clara, et al.
  Udgivet: (2006)
• SETting OP449 into the PP2A-Activating-Drug family
  af: Neviani, Paolo, et al.
  Udgivet: (2014)
• Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia
  af: Leoni, Veronica, et al.
  Udgivet: (2015)
• Wnt/Ca(2+)/NFAT signaling maintains survival of Ph(+) leukemia cells upon inhibition of Bcr-Abl
  af: Gregory, Mark A., et al.
  Udgivet: (2010)